Ashland Inc.

ASH

US0441861046

Diversified Chemicals

Market Closed - Nyse Other stock markets 01:30:02 26/06/2024 am IST			5-day change	1st Jan Change
95.23 ^USD	-2.48%		-2.42%	+12.95%

18/06	Ashland Gets Fair Wage Network Certification	MT
04/06	Ashland Inc. Appoints Alessandra Faccin as Senior Vice President and General Manager, Life Sciences, Effective June 10, 2024	CI

Cruiser Capital Gives Presentation to Shareholders of Ashland Global

January 15, 2019 at 03:45 am IST

On January 14, 2019, Cruiser Capital Master Fund LP announced that it has given presentation to shareholders of Ashland Global Holdings Inc. in connection with the Company’s 2019 annual shareholders meeting.

Latest news about Ashland Inc.

Ashland Gets Fair Wage Network Certification	18/06	MT
Ashland Inc. Appoints Alessandra Faccin as Senior Vice President and General Manager, Life Sciences, Effective June 10, 2024	04/06	CI
Ashland Inc. Appoints Ashish K. Kulkarni as Director	09/05	CI
Ashland Inc. Expects Impairment Charges for the Third Quarter of Fiscal 2024	08/05	CI
Ashland Inc. Authorizes Quarterly Dividend, Payable on June 15, 2024	08/05	CI
BMO Capital Adjusts Price Target on Ashland to $105 From $97, Maintains Market Perform Rating	07/05	MT
Ashland to Sell Nutraceuticals Business to Turnspire Capital	07/05	MT
Turnspire Capital Partners LLC entered into a definitive agreement nutraceuticals business of Ashland Inc (NYSE: ASH).	07/05	CI
JPMorgan Adjusts Price Target on Ashland to $90 From $88, Maintains Underweight Rating	02/05	MT
UBS Adjusts Ashland Price Target to $116 From $114, Maintains Buy Rating	01/05	MT
Ashland Seeks Bolt-On M&A Opportunities	01/05	CI
Transcript : Ashland Inc., Q2 2024 Earnings Call, May 01, 2024	01/05
Tranche Update on Ashland Inc.'s Equity Buyback Plan announced on June 28, 2023.	01/05	CI
Ashland Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	01/05	CI
Ashland Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024	01/05	CI
Ashland Inc. Announces Resignation of Ashok Kalyana as Senior Vice President, and General Manager, Life Sciences and Intermediates, Effective May 10, 2024	30/04	CI
Ashland Inc Appoints Scott A. Tozier to its Board of Directors	15/04	CI
North American Morning Briefing : Big Banks Kick -2-	12/04	DJ
Wells Fargo Upgrades Ashland to Overweight From Equalweight, Raises Price Target to $112 From $100	11/04	MT
Active Energy to abandon flagship project in Maine	09/04	AN
UBS Adjusts Ashland Price Target to $114 From $105, Maintains Buy Rating	08/04	MT
North American Morning Briefing : Inflation -2-	15/03	DJ
Jefferies Upgrades Ashland to Buy From Hold, Adjusts Price Target to $126 From $100	14/03	MT
EARNINGS AND TRADING: Challenger signs farm-out; Ricardo revenue up	06/03	AN
AIM WINNERS & LOSERS: Challenger Energy up on Chevron farm-out deal	06/03	AN

Chart Ashland Inc.

Duration

Period

More charts

Company Profile

Ashland Inc. is a global specialty additives and materials company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The Company's segments include life sciences, personal care, specialty additives and intermediates. The life sciences segment is comprised of pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films and fine chemicals. The personal care segment is comprised of bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The specialty additives segment is comprised of rheology and additives serving the architectural coatings, construction, energy, automotive and various industrial markets. Its Intermediates segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.

Sector

Diversified Chemicals

Calendar

23/07/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Ashland Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

95.23 USD

Average target price

109.8 USD

Spread / Average Target

+15.30%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
ASHLAND INC.	+12.95%	477.36Cr
SHIN-ETSU CHEMICAL CO., LTD.	+5.07%	7.62TCr
BASF SE	-6.34%	4.43TCr
DUPONT DE NEMOURS, INC.	+4.59%	3.36TCr
PIDILITE INDUSTRIES LIMITED	+16.90%	1.91TCr
EASTMAN CHEMICAL COMPANY	+9.05%	1.15TCr
BRENNTAG SE	-22.98%	1TCr
SYENSQO SA/NV	-5.83%	999.96Cr
ASAHI KASEI CORPORATION	-1.35%	896.42Cr
SRF LIMITED	-3.15%	851.23Cr

Diversified Chemicals

Ashland Inc.

Equities

ASH

US0441861046

Diversified Chemicals

Cruiser Capital Gives Presentation to Shareholders of Ashland Global

EPS Revisions